Patents-Review.com
ClassID:

20124 ⎘

A61K9/2833 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials Organic macromolecular compounds

Sub-classes:
Recent Application in this class:
#1
20260097014
2026-04-09

FORMULATIONS OF AG10

 #2
20260027061
2026-01-29

THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

 #3
20260021064
2026-01-22

ACETAMINOPHEN AND NAPROXEN FOR TREATING PAIN

 #4
20260014158
2026-01-15

USE OF VIBEGRON TO TREAT OVERACTIVE BLADDER

 #5
20250302871
2025-10-02

COLONIC PURGATIVE COMPOSITION

 #6
20250281413
2025-09-11

PHARMACEUTICAL COMPOSITION

 #7
20250228820
2025-07-17

METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS DISPLAYING NORMAL COGNITIVE PERFORMANCE

 #8
20250134880
2025-05-01

C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS

 #9
20250127823
2025-04-24

COMPOSITIONS AND METHODS OF AFFECTING CYTOKINE LEVELS USING PREVOTELLA HISTICOLA

 #10
20250057811
2025-02-20

FORMULATIONS OF AG10

 #11
20240317771
2024-09-26

SOLID FORMS, PHARMACEUTICAL COMPOSITIONS AND PREPARATION OF HETEROAROMATIC MACROCYCLIC ETHER COMPOUNDS

 #12
20240156804
2024-05-16

C-Met Modulator Pharmaceutical Compositions

 #13
20240130983
2024-04-25

Compounds for treating coronavirus infection

 #14
20230124705
2023-04-20

Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds

 #15
20230041556
2023-02-09

COLONIC PURGATIVE COMPOSITION

 #16
20230022228
2023-01-26

PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG BIS(MONOETHANOLAMINE)

 #17
20220387354
2022-12-08

Compounds for treating corona virus infection

 #18
20220378798
2022-12-01

Therapeutic compositions for treatment of human immunodeficiency virus

 #19
20220370436
2022-11-24

C-Met Modulator Pharmaceutical Compositions

 #20
20220313764
2022-10-06

CORONAVIRUS THERAPEUTIC AGENT INCLUDING Elaeocarpus sylvestris EXTRACT AS ACTIVE INGREDIENT

 #21
20220313661
2022-10-06

Formulations of AG10

 #22
20220265559
2022-08-25

Delayed release deferiprone tablets and methods of using the same

 #23
20220226251
2022-07-21

COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS

 #24
20220096384
2022-03-31

CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES

 #25
20220087999
2022-03-24

C-Met Modulator Pharmaceutical Compositions

 #26
20220031688
2022-02-03

C-Met Modulator Pharmaceutical Compositions

 #27
20220024970
2022-01-27

COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY

 #28
20220000787
2022-01-06

DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF PREDNISONE AND PREPARATION THEREOF

 #29
20210386677
2021-12-16

Delayed release deferiprone tablets and methods of using the same

 #30
20210379050
2021-12-09

C-Met Modulator Pharmaceutical Compositions

 #31
20210346300
2021-11-11

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #32
20210299083
2021-09-30

Uses of halogenated xanthenes in oncology and virology

 #33
20210299055
2021-09-30

Treatment of Solid Cancerous Tumors by Oral Administration of a Halogenated Xanthene

 #34
20210244670
2021-08-12

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #35
20210077495
2021-03-18

Use of vibegron to treat overactive bladder

 #36
20200397841
2020-12-24

Polyherbal composition for preventing and alleviating polycystic ovary syndrome

 #37
20200397706
2020-12-24

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #38
20200397705
2020-12-24

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #39
20200330433
2020-10-22

EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST

 #40
20200330389
2020-10-22

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #41
20200268672
2020-08-27

Delayed release deferiprone tablets and methods of using the same

 #42
20200253945
2020-08-13

DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME

 #43
20200237674
2020-07-30

Delayed release deferiprone tablets and methods of using the same

 #44
20200222354
2020-07-16

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #45
20200188309
2020-06-18

Delayed release deferiprone tablets and methods of using the same

 #46
20200121671
2020-04-23

C-met modulator pharmaceutical compositions

 #47
20200113840
2020-04-16

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #48
20200054607
2020-02-20

Formulations of AG10

 #49
20190374474
2019-12-12

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR WEIGHT LOSS

 #50
20190358190
2019-11-28

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #51
20190125682
2019-05-02

Delayed release deferiprone tablets and methods of using the same

 #52
20190117581
2019-04-25

Delayed release deferiprone tablets and methods of using the same

 #53
20180344749
2018-12-06

CONTROLLED RELEASE FORMULATIONS OF SALICLATE-RELEASING ACTIVES

 #54
20180318246
2018-11-08

PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE

 #55
20180318222
2018-11-08

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #56
20180311229
2018-11-01

C-Met modulator pharmaceutical compositions

 #57
20180263946
2018-09-20

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #58
20180185319
2018-07-05

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #59
20170319477
2017-11-09

INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME

 #60
20170266178
2017-09-21

C-met modulator pharmaceutical compositions

 #61
20170143689
2017-05-25

C-Met modulator pharmaceutical compositions

 #62
20170056356
2017-03-02

UTILIZATION OF DIALKYL FUMARATES IN TREATMENT OF HEART FAILURE

 #63
20160324774
2016-11-10

Ingestible formulations for transient, noninvasive reduction of gastric volume

 #64
20160317505
2016-11-03

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

 #65
20160106760
2016-04-21

Topically active steroids for use in interstitial pulmonary fibrosis

 #66
20150374713
2015-12-31

STABLE PHARMECEUTICAL COMPOSITION OF AMLODIPINE AND BENAZEPRIL OR SALTS THEREOF

 #67
20150209318
2015-07-30

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #68
20150150814
2015-06-04

STABLE ORAL PHARMACEUTICAL COMPOSITION OF SOLIFENACIN

 #69
20150037405
2015-02-05

PHARMACEUTICAL COMPOSITIONS OF LEVODOPA AND CARBIDOPA

 #70
20140377353
2014-12-25

PHARMACEUTICAL PRODUCT TO INDUCE ENDOGENOUS EXACERBATED RELEASE OF GUT HORMONES PYY AND GLP1 WITH THERAPEUTIC EFFECT ON OBESITY AND TYPE 2 DIABETES MELLITUS

 #71
20140271851
2014-09-18

ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS

 #72
20140271850
2014-09-18

Controlled-Release Pharmaceutical Compositions Comprising Lamotrigine and Methods of Producing Same

 #73
20140186287
2014-07-03

Ingestible formulations for transient, noninvasive reduction of gastric volume

 #74
20140023710
2014-01-23

MILNACIPRAN FORMULATIONS

 #75
20120196936
2012-08-02

Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders

 #76
20120156294
2012-06-21

Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration

 #77
20120076865
2012-03-29

CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES

 #78
20110311620
2011-12-22

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

 #79
20110123573
2011-05-26

Methods and compositions for treating phenylketonuria

 #80
20110027324
2011-02-03

O-DESMETHYL-VENLAFAXINE FOR TREATING MAJOR DEPRESSIVE DISORDER

 #81
20110015166
2011-01-20

Topically active steroids for use in interstitial pulmonary fibrosis

 #82
20100286260
2010-11-11

MILNACIPRAN FORMULATIONS

 #83
20080241094
2008-10-02

Ingestible formulations for transient, noninvasive reduction of gastric volume

 #84
20080003287
2008-01-03

Extended release perforated tablet

 #85
20070134330
2007-06-14

Methods and compositions for improved image quality

 #86
20060075927
2006-04-13

Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same

 #87
20050129728
2005-06-16

Sustained release pharmaceutical composition

 #88
20050037074
2005-02-17

Delayed and sustained drug release